1. Cuproptosis in cancer: biological implications and therapeutic opportunities
    Liping Li et al, 2024, Cellular & Molecular Biology Letters CrossRef
  2. Association between Polymorphism of Genes IL-1A, NFKB1, PAR1, TP53, and UCP2 and Susceptibility to Non-Small Cell Lung Cancer in the Brazilian Amazon
    Esdras E. B. Pereira et al, 2023, Genes CrossRef
  3. Synthesis and neuroprotective effects of new genipin derivatives against glutamate-induced oxidative damage
    Liping Luo et al, 2023, Fitoterapia CrossRef
  4. UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect
    Emily G. Caggiano et al, 2024, Cancer and Metastasis Reviews CrossRef
  5. CD133 increases oxidative glucose metabolism of HT29 cancer cells by mitochondrial uncoupling and its inhibition enhances reactive oxygen species-inducing therapy
    Jin Hee Lee et al, 2022, Nuclear Medicine Communications CrossRef
  6. Role of UCP2 in the Energy Metabolism of the Cancer Cell Line A549
    Jessica Segalés et al, 2023, International Journal of Molecular Sciences CrossRef
  7. Copper in cancer: from limiting nutrient to therapeutic target
    Xiaolong Tang et al, 2023, Frontiers in Oncology CrossRef
  8. Novel Findings regarding the Bioactivity of the Natural Blue Pigment Genipin in Human Diseases
    Magdalena Bryś et al, 2022, International Journal of Molecular Sciences CrossRef
  9. UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control
    Angèle Luby et al, 2022, International Journal of Molecular Sciences CrossRef
  10. Cuproptosis in lung cancer: mechanisms and therapeutic potential
    Qixuan Li et al, 2024, Molecular and Cellular Biochemistry CrossRef
  11. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
    Peijie Zheng et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
  12. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications
    Mojtaba Tarin et al, 2023, Journal of Translational Medicine CrossRef
  13. Genipin, an Inhibitor of UCP2 as a Promising New Anticancer Agent: A Review of the Literature
    Young Seok Cho, 2022, International Journal of Molecular Sciences CrossRef
  14. Brown adipocytes promote epithelial mesenchymal transition of neuroblastoma cells by inducing PPAR-γ/UCP2 expression
    Zhijuan Ge et al, 2022, Adipocyte CrossRef
  15. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway
    Ke-Xin Sun et al, 2023, World Journal of Diabetes CrossRef
  16. UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF‐1α signaling
    Cailu Song et al, 2024, Cancer Medicine CrossRef